AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis

RecruitingNAAges 18 Years - 60 YearsAllInsel Gruppe AG, University Hospital Bern
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Plantar fasciitis is the classic and most common type of heel pain. Considering the costs for health care and the temporary disability not only for work, plantar fasciitis results in a substantial (and at least partially unnecessary) burden for the Swiss health care system and national economics. Nonoperative treatment is the mainstay of treating plantar fasciitis. However, so far no treatment has proven to be superior to others, and there is national and international lack of consensus of how to treat plantar fasciitis best. The investigators believe that the BTX-A injection in the gastrocnemius and the soleus muscles is currently the most promising non-operative approach, because it is considered to treat the disease at its origin (temporary weakening of the tight triceps surae muscle) as opposed to simply alleviate the symptoms (e.g. plantar cortisone and other injections, ESWT). H

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Clinical symptoms of a plantar fasciitis * Plantar fasciitis in MRI * Exclusion of differential diagnoses * Symptoms more than 3 months * Absolution of 3 months unsuccessful treatment * Written informed consent Exclusion Criteria * Active differential diagnoses * Contraindications: pregnancy and breastfeeding, infection at injection sites, allergy against BTX-A * Previous injections or surgery for plantar fasciitis * Neurological diseases affecting the peripheral nervous system
๐Ÿ’Š

What it tests

  • Botulinum toxin A
  • cortisone
  • Saline
๐Ÿ“

Where

2 sites
Dep, of Orthopaedic Surgery, Inselspital, University of Berne
Bern, Switzerland
Department of Orthopaedic Surgery, Kantonsspital Lucerne
Lucerne, Switzerland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy